AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
JAVMA news
FDA opens access to adverse event data
The Food and Drug Administration is offering data about adverse events in animals that can be useful for researchers and software developers.
JAVMA news
CAPC warns care delays may leave pets vulnerable to parasites
Leaders of the Companion Animal Parasite Council recommend that veterinarians consider sending reminders to clients earlier about parasite protection…
AVMA news
11 technologies veterinary practices can adopt today
New devices and software promise to help enhance patient care and monitoring, ease workloads, improve workflows, meet or exceed client expectations,…
blog
Opioid shortage and abuse: Resources and education for veterinarians
The AVMA has good news to help our members advance high-quality patient care in the face of continuing opioid shortages: We’ve teamed up with VetBloom…
JAVMA news
Back to Basics
Veterinarians today are able to provide better and more advanced medical care for pets than ever before, but the cost of that care makes it out of…
JAVMA news
Drug changes not affecting pig health, so far
Federal controls over antimicrobial access and use increased at the end of 2016, requiring veterinarian oversight of hundreds of drug applications.
blog
CDC announces priorities for distributing COVID-19 vaccine
A new interim guide issued by the U.S. Centers for Disease Control and Prevention (CDC) suggests that veterinary team members may have access to an…
JAVMA news
Veterinarians push against restriction of ketamine
The AVMA and many members have submitted comments emphasizing the importance of access to ketamine ahead of a review by a World Health Organization…
policy
Safety testing
The AVMA supports research to discover and develop safe and efficacious drugs, vaccines, biologicals, and medical devices that benefit animals and…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
FDA issues draft guidance on compounding
AVMA is undertaking a careful review of the proposal with broad input from AVMA members and other veterinary stakeholders. We'll work with FDA to…
JAVMA news
Model law: Pharmacies should keep a reference on veterinary drugs
The National Association of Boards of Pharmacy recently amended the NABP Model State Pharmacy Act to require pharmacies that dispense
JAVMA news
DEA issues pain medication FAQ
The Drug Enforcement Administration has issued a frequently asked questions document to cover
blog
Compounding: How do new rules affect you?
The FDA says it will start phasing in inspectional activities in April for its new guidance on compounding from bulk drug substances. Here’s what…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
Antimicrobials
Veterinarians are leaders and stewards in preserving the effectiveness of antimicrobials. We work conscientiously with antimicrobial drugs,…
JAVMA news
Watch for number of refills requested
TAKE NOTICE Watch for number of refills requested Veterinarians are reporting that some Internet…
AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
JAVMA news
FDA may change drug uses in 5-year plan
Federal authorities plan to expand limits on who can buy antimicrobials for use in livestock and how long they can be used.
blog
Advocacy update: Illicit xylazine, retirement saving, and budget wins
What's happening in Washington, D.C., that affects you? The AVMA's Capitol Hill update outlines some of the most recent developments.
AVMA news
FDA extends educational period for new policy on compounding animal drugs from bulk drug substances
The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances.
JAVMA news
Dispensing foreign products constitutes drug diversion
Dispensing foreign products constitutes drug diversion
JAVMA news
In video, FDA urges adverse event reporting
Whenever an animal drug is linked to an adverse event—in an animal or a person—Food and Drug Administration officials want to know about it.
AVMA news
Telehealth bill advances in California Senate
California Assembly Bill 1399 passed the California Senate Appropriations Committee on September 1. The bill would allow a…